MSB 8.37% $1.15 mesoblast limited

Cell Therapy News/Articles, page-17702

  1. 2,746 Posts.
    lightbulb Created with Sketch. 1843
    Just a reminder about the potential for label extension into the adult market.
    The approved therapy does not improve survival.
    Pay attention to Chronic aGvHD- off label coming soon to a cinema near you.

    Reg

    all speculative of course


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.